Deerfield Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,815
Closed -$2.09M 126
2025
Q4
$2.09M Sell
25,815
-4,144
-14% -$357K 0.03% 96
2025
Q3
$2.62M Buy
29,959
+25,790
+619% +$2.3M 0.04% 93
2025
Q2
$346K Buy
+4,169
New +$348K 0.01% 90
2024
Q2
Sell
-6,770
Closed -$449K 512
2024
Q1
$449K Buy
+6,770
New +$418K 0.01% 163

Other funds holding LMAT

Deerfield Management's LMAT Position: Q1 2026 in Review

Deerfield Management sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 25,815 shares — an estimated $2.09M sold.

Deerfield Management first reported a position in LMAT in Q1 2024 and held it in 4 quarters. The position peaked at $2.62M in Q3 2025. 340 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Deerfield Management reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • Deerfield Management sold 25,815 LeMaitre Vascular shares in Q1 2026, an estimated $2.09M.
  • Deerfield Management first reported a position in LeMaitre Vascular in Q1 2024 and held it in 4 quarters.
  • Deerfield Management's LeMaitre Vascular position peaked at $2.62M in Q3 2025.
  • 340 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.